Moreover, crossing leptin deficient or insensitive mice (ob/ob or db/db) with AD transgenic mouse models (APP23 or tauP301L) exacerbates AD-related pathology thereby providing further evidence that impairments in the leptin system may accelerate AD neurodegeneration [100, 101]. This evidence concerns the gene LEP and Alzheimer disease.